NCT00619216 Myfortic Conversion Trial in OLT Recipients With GI Intolerance Status COMPLETED Phase N/A
NCT00615927 Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG) Status COMPLETED Phase PHASE2
NCT00613171 Efficacy and Tolerability of STI571 (Imatinib Mesylate) for the Treatment of Fibrosis in Participants With Systemic Sclerosis Status COMPLETED Phase PHASE2
NCT00613132 Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG Status COMPLETED Phase PHASE1
NCT00613054 Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma Status COMPLETED Phase PHASE1
NCT00601978 Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off Status WITHDRAWN Phase PHASE4
NCT00600938 Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload Status COMPLETED Phase PHASE2
NCT00600886 Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly Status COMPLETED Phase PHASE3
NCT00600275 A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00599326 Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda Status COMPLETED Phase PHASE3
NCT00597506 Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus Status COMPLETED Phase PHASE2
NCT00584740 Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease Status TERMINATED Phase PHASE2
NCT00582738 Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection Status TERMINATED Phase PHASE2
NCT00582556 Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy Status COMPLETED Phase PHASE2
NCT00582426 Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea Status COMPLETED Phase PHASE3
NCT00581997 QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis Status TERMINATED Phase PHASE2
NCT00574743 Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Comparison to Mycophenolate Mofetil (MMF) in de Nove Heart Patients Status COMPLETED Phase PHASE4